Hologic, Inc. (VIE:HOLX)
Austria · Delayed Price · Currency is EUR 63.50
0.00 (0.00%)
Last updated: Feb 3, 2026, 11:00 AM CET
Hologic Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 27, 2025 | Sep '25 Sep 27, 2025 | Sep '24 Sep 28, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 24, 2022 | Sep '21 Sep 25, 2021 |
| 4,127 | 4,101 | 4,030 | 4,030 | 4,863 | 5,632 | |
Revenue Growth (YoY) | 2.17% | 1.74% | -0.00% | -17.12% | -13.66% | 49.15% |
Cost of Revenue | 1,635 | 1,607 | 1,583 | 1,574 | 1,552 | 1,560 |
Gross Profit | 2,492 | 2,494 | 2,448 | 2,457 | 3,311 | 4,073 |
Selling, General & Admin | 994.5 | 993.6 | 994.8 | 987.6 | 1,038 | 994.4 |
Research & Development | 248.4 | 248.2 | 272.8 | 294.3 | 283.4 | 276.3 |
Amortization of Goodwill & Intangibles | 183.5 | 190.9 | 209.7 | 233.8 | 340.9 | 318.9 |
Operating Expenses | 1,426 | 1,433 | 1,477 | 1,516 | 1,662 | 1,590 |
Operating Income | 1,065 | 1,061 | 970.2 | 941 | 1,648 | 2,483 |
Interest Expense | -114.2 | -117.1 | -122.1 | -111.1 | -95.1 | -93.6 |
Interest & Investment Income | 69.9 | 74.4 | 108.7 | 120.5 | 12.9 | 1.4 |
Earnings From Equity Investments | -10.3 | -9 | -3.6 | - | - | - |
Currency Exchange Gain (Loss) | -13.6 | 11.6 | -21 | -7.9 | 48.5 | -17.1 |
Other Non Operating Income (Expenses) | 10.1 | 7 | 20.5 | 6.2 | -13.6 | 11.7 |
EBT Excluding Unusual Items | 1,007 | 1,028 | 952.7 | 948.7 | 1,601 | 2,385 |
Merger & Restructuring Charges | -117.7 | -120.9 | -41.1 | -12 | -2.4 | -9.3 |
Gain (Loss) on Sale of Investments | - | - | - | - | -4 | - |
Gain (Loss) on Sale of Assets | - | - | - | -51.7 | - | - |
Asset Writedown | -225.9 | -225.9 | -44.8 | -223.8 | -45.1 | - |
Other Unusual Items | - | - | -1.7 | 14.9 | 38.8 | -14.9 |
Pretax Income | 663.4 | 681.2 | 865.1 | 676.1 | 1,588 | 2,361 |
Income Tax Expense | 119.6 | 115.5 | 75.6 | 220.1 | 286.2 | 491.4 |
Earnings From Continuing Operations | 543.8 | 565.7 | 789.5 | 456 | 1,302 | 1,870 |
Minority Interest in Earnings | - | - | - | - | - | 1.8 |
Net Income | 543.8 | 565.7 | 789.5 | 456 | 1,302 | 1,872 |
Net Income to Common | 543.8 | 565.7 | 789.5 | 456 | 1,302 | 1,872 |
Net Income Growth | -26.91% | -28.35% | 73.14% | -64.98% | -30.43% | 67.82% |
Shares Outstanding (Basic) | 225 | 226 | 236 | 247 | 252 | 257 |
Shares Outstanding (Diluted) | 226 | 228 | 238 | 249 | 254 | 260 |
Shares Change (YoY) | -4.04% | -4.20% | -4.53% | -1.98% | -2.26% | -1.85% |
EPS (Basic) | 2.42 | 2.50 | 3.35 | 1.85 | 5.18 | 7.28 |
EPS (Diluted) | 2.40 | 2.49 | 3.32 | 1.83 | 5.13 | 7.21 |
EPS Growth | -23.84% | -25.00% | 81.42% | -64.33% | -28.85% | 71.26% |
Free Cash Flow | 957.2 | 920.1 | 1,155 | 901 | 1,999 | 2,153 |
Free Cash Flow Per Share | 4.24 | 4.04 | 4.86 | 3.62 | 7.87 | 8.29 |
Gross Margin | 60.38% | 60.82% | 60.73% | 60.95% | 68.08% | 72.31% |
Operating Margin | 25.81% | 25.88% | 24.07% | 23.35% | 33.89% | 44.08% |
Profit Margin | 13.18% | 13.80% | 19.59% | 11.31% | 26.77% | 33.23% |
Free Cash Flow Margin | 23.20% | 22.44% | 28.66% | 22.36% | 41.10% | 38.22% |
EBITDA | 1,351 | 1,351 | 1,265 | 1,264 | 2,078 | 2,890 |
EBITDA Margin | 32.73% | 32.95% | 31.38% | 31.37% | 42.74% | 51.31% |
D&A For EBITDA | 285.6 | 290 | 294.5 | 323.4 | 430.1 | 406.9 |
EBIT | 1,065 | 1,061 | 970.2 | 941 | 1,648 | 2,483 |
EBIT Margin | 25.81% | 25.88% | 24.07% | 23.35% | 33.89% | 44.08% |
Effective Tax Rate | 18.03% | 16.96% | 8.74% | 32.55% | 18.02% | 20.81% |
Revenue as Reported | 4,127 | 4,101 | 4,030 | 4,030 | 4,863 | 5,632 |
Advertising Expenses | - | 24.7 | 22.6 | 31.4 | 78.1 | 9.8 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.